LUDWIG ENTERPRISES, INC. (LUDG) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US54973P4019
LUDWIG ENTERPRISES, INC. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -1.77 m USD |
| EBIT | -2.15 m USD |
| Net income | -2.24 m USD |
| Diluted EPS – continuing operations | -0.01 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LUDWIG ENTERPRISES, INC.
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecular signatures in mRNA expression associated with inflammation-related biological processes associated with the presence of breast cancer. Ludwig Enterprises, Inc. was founded in 1988 and is based in Miami, Florida.
More stocks
- Rapid Line Inc. (RPDL)
- TANCHENG GROUP CO., LTD. (QSJC)
- Wheeler Real Estate Investment Trust, Inc. (WHLR)
- VIVIC CORP. (VIVC)
- Video River Networks, Inc. (NIHK)
- Hestia Insight Inc. (HSTA)
- Omnitek Engineering Corp (OMTK)
- Karyopharm Therapeutics Inc. (KPTI)
- Bright Mountain Media, Inc. (BMTM)
- Exousia Bio, Inc. (LMMY)
- SHARING ECONOMY INTERNATIONAL INC. (SEII)
- Leslie's, Inc. (LESL)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.